Delayed Neurological Complications of Sulphur Mustard and Tabun Poisoning in 43 Iranian Veterans

Basic and Clinical Pharmacology and Toxicology

Volumn 111, Issue 6, 2012, Pages 426-432

  Darchini Maragheh, Emadodin ^a,b   Nemati Karimooy, Habibollah ^a   Hasanabadi, Hosein ^a   Balali Mood, Mahdi ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BILIRUBIN GLUCURONIDE; CHOLESTEROL; LACTATE DEHYDROGENASE; LOW DENSITY LIPOPROTEIN; MUSTARD GAS; TABUN; TRIACYLGLYCEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMNESIA; ANXIETY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BABINSKI REFLEX; BILIRUBIN BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONCENTRATION LOSS; DELAYED NEUROTOXICITY; DEMOGRAPHY; DEPRESSION; DYSARTHRIA; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; EMOTIONAL STABILITY; FATIGUE; HEADACHE; HEARING IMPAIRMENT; HUMAN; HYPERESTHESIA; HYPESTHESIA; HYPOSMIA; IMPOTENCE; INFORMED CONSENT; INSOMNIA; IRAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LIBIDO DISORDER; LIPOPROTEIN BLOOD LEVEL; MALE; NERVE CONDUCTION; NEUROLOGIC EXAMINATION; NEUROLOGIST; NYSTAGMUS; PARALYSIS; PARESTHESIA; PRIORITY JOURNAL; PROFESSIONAL STANDARD; SEIZURE; TREMOR; TRIACYLGLYCEROL BLOOD LEVEL; VETERAN; WAR; WEAKNESS;

ADULT; CHEMICAL WARFARE AGENTS; CROSS-SECTIONAL STUDIES; ELECTROPHYSIOLOGICAL PHENOMENA; HUMANS; IRAN; LINEAR MODELS; MALE; MIDDLE AGED; MUSTARD GAS; NERVOUS SYSTEM DISEASES; ORGANOPHOSPHATES; TIME FACTORS; VETERANS;

EID: 84869155170     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2012.00922.x     Document Type: Article

References (47)

1. World Health Organization. Public health response to biological and chemical weapons. WHO guidance: 2001; 143-213.
2. Khateri S. Statistical views on late complications of chemical weapons on Iranian CW victims. The ASA newsletter, No. 85, 31 August 2001; 1: 16-9.
3. Mazandarani M. Secretary-General of the Association for Helping Victims of Iraq's Chemical Warfare with Iran. Statement reported by the Islamic Republic News Agency, 1 December 1996.
4. Balali-Mood M, Balali-Mood K. Nerve agents. In: Brent J (ed.). Critical Care Toxicology. Elsevier Mosby, Philadelphia, PA, 2005;1379-93.
5. Balali-Mood M, Balali-Mood K. Neurotoxic disorders of organophosphorus compounds and their managments. Arch Iran Med 2008;11:65-89.
6. Hilmas CJ, Smart JK, Hill BA.History of chemical warfare. Chapter 2 in Lenhart, MK, Editor-in chief (2008), Borden Institute: GPO, pg 62.
7. Casida JE, Quistad GB. Organophosphate toxicology: safety aspects of nonacetylcholinesterase secondary targets. Chem Res Toxicol 2004;17:983-98.
8. Vassiliki A, Figueriredo H, Apland J, Qashu F, Braga FM, Braga M. Primary brain targets of nerve agents. Neurotoxicology 2009;30:772-726. Epub 2009 Jul 8.
9. Newmark J. Nerve agents. Neurologist 2007;13:20-32.
10. Sidell FR. Soman and sarin: clinical manifestations and treatment of accidental poisoning by organophosphates. Clin Toxicol (Phila) 1974;7:1-17.
11. Yaganisawa N, Morita H, Nakajima T. Sarin experiences in Japan: acute toxicity and long-term effects. J Neurol Sci 2006;249:76-85.
12. Cannard K. The acute treatment of nerve agent exposure. J Neurol Sci 2006;249:86-94.
13. Abdollahi M, Karami-Mohajeri S. A comprehensive review on experimental and clinical findings in intermediate syndrome by organophosphate poisoning. Toxicol Appl Pharmacol 2012;258:309-14.
14. Balali-Mood M, Navaeian A. Clinical and paraclinical findings in 233 patients with sulfur mustard poisoning. In: Heyndrickx B (ed.). Proceedings of the Second World Congress on New Compounds in Biological and Chemical Warfare: Toxicological Evaluation. Ghent University Press, Ghent, Belgium, 1986; 464-73.
15. Koc F, Yerdelen D, Kekec Z. Myeloneuritis due to acute organophosphate (DDVP) intoxication. Int J Neurosci 2009;119:1538-47.
16. Senanayake N, Karalliede L. Neurotoxic effects of organophosphorous insecticides. An intermediate syndrome. N Engl J Med 1987;316:761-3.
17. Willems JL. Clinical management of mustard gas casualties. Ann Med Mil Belg 1989;3:S1-61.
18. Balali-Mood M, Hefazi M. The pharmacology, toxicology, and medical treatment of sulfur mustard poisoning. Fundam Clin Pharmacol 2005;19:297-315.
19. Balali-Mood M, Hefazi M, Mahmoudi M, Jalali E, Attaran D, Maleki M, et al. Long-term complications of sulphur mustard poisoning in severely intoxicated Iranian veterans. Fundam Clin Pharmacol 2005;19:713-21.
20. Emerick GL, Peccinini RG, de Oliveira GH. Organophosphorus-induced delayed neuropathy: a simple and efficient therapeutic strategy. Toxicol Lett 2010;192:238-44.
21. Rickett D, Glenn J, Beers E. Central respiratory effects versus neuromuscular actions of nerve agents. Neurotoxicology 1953;8:466-75.
22. Jokanović M, Kosanović M, Brkić D, Vukomanović P. Organophosphate induced delayed polyneuropathy in man: an overview. Clin Neurol Neurosurg 2011;113:7-10.
23. Peter JV, Prabhakar AT, Pichamuthu K. Delayed-onset encephalopathy and coma in acute organophosphate poisoning in humans. Neurotoxicology 2008;29:335-42.
24. Watson AP, Jones TD, Griffin GD. Sulfur mustard as a carcinogen: application of relative potency analysis to the chemical warfare agents H, HD, and HT. Regul Toxicol Pharmacol 1989;10:1-25.
25. Balali-Mood M, Hefazi M. Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. Basic Clin Pharmacol Toxicol 2006;99:273-82.
26. Perrotta DM. Environment Committee Armed Forces Epidemiological Board long-term health effects associated with sub-clinical exposures to GB and mustard. Gulflink: Office of the Special Assistant for Gulf War Illnesses; 1996. Available at www.gulflink.osd.mil/agent.html.
27. Lotti M, Moretto A. Promotion of organophosphate induced delayed polyneuropathy by certain esterase inhibitors. Chem Biol Interact 1999;119-120:519-524.
28. Abu-Qare AW, Abou-Donia MB. Sarin: health effects, metabolism, and methods of analysis. Food Chem Toxicol 2002;40:1327-33.
29. Nakajima T, Ohta S, Fukushima Y, Yanagisawa N. Sequelae of sarin toxicity at one and three years after exposure in Matsumoto, Japan. J Epidemiol 1999;9:337-43.
30. Engel CC, Jaffer A, Adkins J, Riddle JR, Gibson R. Can we prevent a second 'Gulf War syndrome'? Population-based healthcare for chronic idiopathic pain and fatigue after war Adv Pssychosom Med 2004;25:102-22.
31. Martyn CN, Hughes RA. Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry 1997;62:310-8.
32. Beghi E, Monticelli ML. Chronic symmetric symptomatic polyneuropathy in the elderly: a field screening investigation of risk factors by for polyneuropathy in The Two Italian Communities. Italian General Practitioner Study Group (IGPST). J Clin Epidemiol 1998;51:697-702.
33. Forestier N, Bouche P. Neuropathies in the elderly: causes and practical driving. Cytokine Aging 2006;4:109-19.
34. Imreova H, Pura M, Cesk CL. Differential diagnosis of peripheral neuropathy. Cas Lek Cesk 2005;144:628-33; discussion 633-5.
35. Amirzargar MA, Yavangi M, Rahnavardi M, Jafari M, Mohseni M. Chronic mustard toxicity on the testis: a historical cohort study two decades after exposure. Int J Androl 2009;32:411-6.
36. Ghanei M, Rajaee M, Khateri S, Alaeddini F, Haines D. Assessment of fertility among mustard-exposed residents of Sardasht, Iran: a historical Cohort study. Reprod Toxicol 2004;18:635-9.
37. Moghadam-Kia S, Werth VP. Prevention and treatment of systemic glucocorticoid side effects. Int J Dermatol 2010;49:239-48.
38. Page WF. Long-term health effects of exposure to sarin and other anticholinesterase chemical warfare agents. Mil Med 2003;168:239-45.
39. Craig AB, Freeman G. Clinical Observations on Workers Accidentally Exposed to "G" Agents. Medical Research Laboratory, Edgewood Arsenal, MD, 1953. Medical Laboratory Research Report 154.
40. Brody BB, Gammill JF. Seventy-five Cases of Accidental Nerve Gas Poisoning at Dugway Proving Ground. Medical Investigational Branch, Dugway Proving Ground, UT, 1954. Medical Investigational Branch Special Report 5.
41. Young JF, Gough BJ, Suber RL, Gaylor DW. Correlation of blood cholinesterase levels with toxicity of sarin in rats. J Toxicol Environ Health 2001;62:161-74.
42. Newmark J. Nerve agents: Pathophysiology and treatment of posoning. Semin Neurol 2004;24:185-96.
43. Duffy FH, Burchfiel JL, Bartels PH, Gaon M, Sim VM. Long-term effects of an organophosphate upon the human electroencephalogram. Toxicol Appl Pharmacol 1979;47:161-76.
44. Holisaz MT, Rayegani SM, Hafezy R, Khedmat H, Motamedi MH. Screening for peripheral neuropathy in chemical warfare victims. Int J Rehabil Res 2007;30:71-4.
45. Wang L, Liu YH, Xu Y, Yin W, Huang YG. Thirteen-year follow-up of patients with tri-ortho-cresyl phosphate poisoning in northern suburbs of Xi'an in China. Neurotoxicology 2009;30:1084-7.
46. Wadia RS, Chitra S, Amin RB, Kiwalkar RS, Sardesai HV. Electrophysiological studies in acute organophosphate poisoning. J Neurol Neurosurg Psychiatry 1987;50:1442-8.
47. World Health Organization. Preventing and Managing the Global Epidemic: Report of WHO Consultation on Obesity. WHO, Geneva, 1998.